Literature DB >> 25271315

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Lindsay M Morton1, Ethel S Gilbert2, Marilyn Stovall3, Flora E van Leeuwen4, Graça M Dores5, Charles F Lynch6, Per Hall7, Susan A Smith3, Rita E Weathers3, Hans H Storm8, David C Hodgson9, Ruth A Kleinerman2, Heikki Joensuu10, Tom Børge Johannesen11, Michael Andersson12, Eric J Holowaty13, Magnus Kaijser14, Eero Pukkala15, Leila Vaalavirta10, Sophie D Fossa16, Frøydis Langmark11, Lois B Travis17, Stephanie Lamart2, Steven L Simon2, Joseph F Fraumeni2, Berthe M Aleman18, Rochelle E Curtis2.   

Abstract

Entities:  

Keywords:  Hodgkin lymphoma; esophageal cancer; late effects; radiotherapy

Mesh：

Year:  2014        PMID： 25271315      PMCID： PMC4181268          DOI： 10.3324/haematol.2014.108258

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Lung cancer after treatment for Hodgkin's disease: focus on radiation effects.

Authors:  E S Gilbert; M Stovall; M Gospodarowicz; F E Van Leeuwen; M Andersson; B Glimelius; T Joensuu; C F Lynch; R E Curtis; E Holowaty; H Storm; E Pukkala; M B van't Veer; J F Fraumeni; J D Boice; E A Clarke; L B Travis
Journal:  Radiat Res       Date:  2003-02       Impact factor: 2.841

3.  Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.

Authors:  C Metayer; C F Lynch; E A Clarke; B Glimelius; H Storm; E Pukkala; T Joensuu; F E van Leeuwen; M B van't Veer; R E Curtis; E J Holowaty; M Andersson; T Wiklund; M Gospodarowicz; L B Travis
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

4.  Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Authors:  David C Hodgson; Ethel S Gilbert; Graça M Dores; Sara J Schonfeld; Charles F Lynch; Hans Storm; Per Hall; Froydis Langmark; Eero Pukkala; Michael Andersson; Magnus Kaijser; Heikki Joensuu; Sophie D Fosså; Lois B Travis
Journal:  J Clin Oncol       Date:  2007-03-19       Impact factor: 44.544

5.  Cancer mortality following X-ray treatment for ankylosing spondylitis.

Authors:  H A Weiss; S C Darby; R Doll
Journal:  Int J Cancer       Date:  1994-11-01       Impact factor: 7.396

6.  Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Authors:  Lois B Travis; Mary Gospodarowicz; Rochelle E Curtis; E Aileen Clarke; Michael Andersson; Bengt Glimelius; Timo Joensuu; Charles F Lynch; Flora E van Leeuwen; Eric Holowaty; Hans Storm; Ingrid Glimelius; Eero Pukkala; Marilyn Stovall; Joseph F Fraumeni; John D Boice; Ethel Gilbert
Journal:  J Natl Cancer Inst       Date:  2002-02-06       Impact factor: 13.506

7.  Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.

Authors:  Graça M Dores; Catherine Metayer; Rochelle E Curtis; Charles F Lynch; E Aileen Clarke; Bengt Glimelius; Hans Storm; Eero Pukkala; Flora E van Leeuwen; Eric J Holowaty; Michael Andersson; Tom Wiklund; Timo Joensuu; Mars B van't Veer; Marilyn Stovall; Mary Gospodarowicz; Lois B Travis
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

8.  Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis.

Authors:  P M Mauch; L A Kalish; M Kadin; C N Coleman; R Osteen; S Hellman
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

9.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

10.  Stomach cancer risk after treatment for hodgkin lymphoma.

Authors:  Lindsay M Morton; Graça M Dores; Rochelle E Curtis; Charles F Lynch; Marilyn Stovall; Per Hall; Ethel S Gilbert; David C Hodgson; Hans H Storm; Tom Børge Johannesen; Susan A Smith; Rita E Weathers; Michael Andersson; Sophie D Fossa; Michael Hauptmann; Eric J Holowaty; Heikki Joensuu; Magnus Kaijser; Ruth A Kleinerman; Frøydis Langmark; Eero Pukkala; Leila Vaalavirta; Alexandra W van den Belt-Dusebout; Joseph F Fraumeni; Lois B Travis; Berthe M Aleman; Flora E van Leeuwen
Journal:  J Clin Oncol       Date:  2013-08-26       Impact factor: 44.544
View more
  11 in total

Review 1.  The concept and evolution of involved site radiation therapy for lymphoma.

Authors:  Lena Specht; Joachim Yahalom
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

2.  Adaptations to a Generalized Radiation Dose Reconstruction Methodology for Use in Epidemiologic Studies: An Update from the MD Anderson Late Effect Group.

Authors:  Rebecca M Howell; Susan A Smith; Rita E Weathers; Stephen F Kry; Marilyn Stovall
Journal:  Radiat Res       Date:  2019-06-18       Impact factor: 2.841

Review 3.  Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?

Authors:  Lena Specht
Journal:  Curr Treat Options Oncol       Date:  2016-01

4.  Unique Considerations for Females Undergoing Esophagectomy.

Authors:  Tamar B Nobel; Jennifer Livschitz; Mahmoud Eljalby; Yelena Y Janjigian; Manjit S Bains; Prasad S Adusumilli; David R Jones; Daniela Molena
Journal:  Ann Surg       Date:  2020-07       Impact factor: 13.787

5.  Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases.

Authors:  Berbel L M Ykema; Sanne J M Hoefnagel; Lisanne S Rigter; Liudmila L Kodach; Gerrit A Meijer; Flora E van Leeuwen; Hina N Khan; Petur Snaebjornsson; Berthe M P Aleman; Annegien Broeks; Sybren L Meijer; Kenneth K Wang; Beatriz Carvalho; Kausilia K Krishnadath; Monique E van Leerdam
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

6.  Dietary and Environmental Determinants of Oesophageal Cancer in Arsi Zone, Oromia, Central Ethiopia: A Case-Control Study.

Authors:  Haji Aman Deybasso; Kedir Teji Roba; Berhanu Nega; Tefera Belachew
Journal:  Cancer Manag Res       Date:  2021-02-26       Impact factor: 3.989

7.  Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

Authors:  Georgios Ntentas; Katerina Dedeckova; Michal Andrlik; Marianne C Aznar; Rebecca Shakir; Johanna Ramroth; Rubina Begum; Jiří Kubeš; Sarah C Darby; N George Mikhaeel; David J Cutter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-09       Impact factor: 7.038

8.  Persistent mRNA and miRNA expression changes in irradiated baboons.

Authors:  Matthias Port; Francis Hérodin; Marco Valente; Michel Drouet; Patrick Ostheim; Matthäus Majewski; Michael Abend
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

9.  Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Authors:  Georgios Ntentas; Katerina Dedeckova; Michal Andrlik; Marianne C Aznar; Ben George; Jiří Kubeš; Sarah C Darby; David J Cutter
Journal:  Pract Radiat Oncol       Date:  2019-01-29

10.  Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer.

Authors:  Lisanne S Rigter; Michael Schaapveld; Cecile P M Janus; Augustinus D G Krol; Richard W M van der Maazen; Judith Roesink; Josee M Zijlstra; Gustaaf W van Imhoff; Philip M P Poortmans; Max Beijert; Pieternella J Lugtenburg; Otto Visser; Petur Snaebjornsson; Anna M van Eggermond; Berthe M P Aleman; Flora E van Leeuwen; Monique E van Leerdam
Journal:  Cancer Med       Date:  2018-12-27       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.